Literature DB >> 26056932

Human polyomavirus receptor distribution in brain parenchyma contrasts with receptor distribution in kidney and choroid plexus.

Sheila A Haley1, Bethany A O'Hara1, Christian D S Nelson1, Frances L P Brittingham1, Kammi J Henriksen2, Edward G Stopa2, Walter J Atwood3.   

Abstract

The human polyomavirus, JCPyV, is the causative agent of progressive multifocal leukoencephalopathy, a rare demyelinating disease that occurs in the setting of prolonged immunosuppression. After initial asymptomatic infection, the virus establishes lifelong persistence in the kidney and possibly other extraneural sites. In rare instances, the virus traffics to the central nervous system, where oligodendrocytes, astrocytes, and glial precursors are susceptible to lytic infection, resulting in progressive multifocal leukoencephalopathy. The mechanisms by which the virus traffics to the central nervous system from peripheral sites remain unknown. Lactoseries tetrasaccharide c (LSTc), a pentasaccharide containing a terminal α2,6-linked sialic acid, is the major attachment receptor for polyomavirus. In addition to LSTc, type 2 serotonin receptors are required for facilitating virus entry into susceptible cells. We studied the distribution of virus receptors in kidney and brain using lectins, antibodies, and labeled virus. The distribution of LSTc, serotonin receptors, and virus binding sites overlapped in kidney and in the choroid plexus. In brain parenchyma, serotonin receptors were expressed on oligodendrocytes and astrocytes, but these cells were negative for LSTc and did not bind virus. LSTc was instead found on microglia and vascular endothelium, to which virus bound abundantly. Receptor distribution was not changed in the brains of patients with progressive multifocal leukoencephalopathy. Virus infection of oligodendrocytes and astrocytes during disease progression is LSTc independent.
Copyright © 2015 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26056932      PMCID: PMC4530127          DOI: 10.1016/j.ajpath.2015.04.003

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  94 in total

1.  Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease.

Authors:  Gert Van Assche; Marc Van Ranst; Raf Sciot; Bénédicte Dubois; Séverine Vermeire; Maja Noman; Jannick Verbeeck; Karel Geboes; Wim Robberecht; Paul Rutgeerts
Journal:  N Engl J Med       Date:  2005-06-09       Impact factor: 91.245

2.  Detection of polyoma virus DNA in PML-brain tissue by (in situ) hybridization.

Authors:  K Dörries; R T Johnson; V ter Meulen
Journal:  J Gen Virol       Date:  1979-01       Impact factor: 3.891

3.  Epithelial membrane antigen in normal and proteinuric glomeruli and in damaged proximal tubules.

Authors:  A J Howie
Journal:  J Pathol       Date:  1986-01       Impact factor: 7.996

4.  Application of a lectin from the mushroom Polysporus squamosus for the histochemical detection of the NeuAcalpha2,6Galbeta1,4Glc/GlcNAc sequence of N-linked oligosaccharides: a comparison with the Sambucus nigra lectin.

Authors:  V Toma; C Zuber; H C Winter; I J Goldstein; J Roth
Journal:  Histochem Cell Biol       Date:  2001-08       Impact factor: 4.304

5.  Immunohistochemical detection of KI polyomavirus in lung and spleen.

Authors:  Erica A Siebrasse; Nang L Nguyen; Colin Smith; Peter Simmonds; David Wang
Journal:  Virology       Date:  2014-09-03       Impact factor: 3.616

6.  Detection and typing of JC virus in autopsy brains and extraneural organs of AIDS patients and non-immunocompromised individuals.

Authors:  R Caldarelli-Stefano; L Vago; E Omodeo-Zorini; M Mediati; L Losciale; M Nebuloni; G Costanzi; P Ferrante
Journal:  J Neurovirol       Date:  1999-04       Impact factor: 2.643

7.  HIV-1 gp120 upregulates matrix metalloproteinases and their inhibitors in a rat model of HIV encephalopathy.

Authors:  Jean-Pierre Louboutin; Beverly A S Reyes; Lokesh Agrawal; Elisabeth J Van Bockstaele; David S Strayer
Journal:  Eur J Neurosci       Date:  2011-11-17       Impact factor: 3.386

8.  A fatal case of JC virus meningitis presenting with hydrocephalus in a human immunodeficiency virus-seronegative patient.

Authors:  Shruti P Agnihotri; Christian Wuthrich; Xin Dang; David Nauen; Reza Karimi; Raphael Viscidi; Evelyn Bord; Stephanie Batson; Juan Troncoso; Igor J Koralnik
Journal:  Ann Neurol       Date:  2014-06-20       Impact factor: 10.422

9.  A molecular characterization of the choroid plexus and stress-induced gene regulation.

Authors:  M Sathyanesan; M J Girgenti; M Banasr; K Stone; C Bruce; E Guilchicek; K Wilczak-Havill; A Nairn; K Williams; S Sass; J G Duman; S S Newton
Journal:  Transl Psychiatry       Date:  2012-07-10       Impact factor: 6.222

10.  Progressive multifocal leukoencephalopathy-associated mutations in the JC polyomavirus capsid disrupt lactoseries tetrasaccharide c binding.

Authors:  Melissa S Maginnis; Luisa J Ströh; Gretchen V Gee; Bethany A O'Hara; Aaron Derdowski; Thilo Stehle; Walter J Atwood
Journal:  MBio       Date:  2013-06-11       Impact factor: 7.867

View more
  20 in total

1.  Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathy.

Authors:  Ivan Jelcic; Benoit Combaluzier; Ilijas Jelcic; Wolfgang Faigle; Luzia Senn; Brenda J Reinhart; Luisa Ströh; Roger M Nitsch; Thilo Stehle; Mireia Sospedra; Jan Grimm; Roland Martin
Journal:  Sci Transl Med       Date:  2015-09-23       Impact factor: 17.956

2.  JC virus infection of meningeal and choroid plexus cells in patients with progressive multifocal leukoencephalopathy.

Authors:  Sarah M Corbridge; Richard C Rice; Linda A Bean; Christian Wüthrich; Xin Dang; Daniel A Nicholson; Igor J Koralnik
Journal:  J Neurovirol       Date:  2019-04-25       Impact factor: 2.643

3.  Susceptibility of Primary Human Choroid Plexus Epithelial Cells and Meningeal Cells to Infection by JC Virus.

Authors:  Bethany A O'Hara; Gretchen V Gee; Walter J Atwood; Sheila A Haley
Journal:  J Virol       Date:  2018-03-28       Impact factor: 5.103

4.  Converting Pasteurella multocidaα2-3-sialyltransferase 1 (PmST1) to a regioselective α2-6-sialyltransferase by saturation mutagenesis and regioselective screening.

Authors:  John B McArthur; Hai Yu; Jie Zeng; Xi Chen
Journal:  Org Biomol Chem       Date:  2017-01-30       Impact factor: 3.876

5.  CD8 T Cells and STAT1 Signaling Are Essential Codeterminants in Protection from Polyomavirus Encephalopathy.

Authors:  Taryn E Mockus; Colleen S Netherby-Winslow; Hannah M Atkins; Matthew D Lauver; Ge Jin; Heather M Ren; Aron E Lukacher
Journal:  J Virol       Date:  2020-03-31       Impact factor: 5.103

6.  Infectious Entry and Neutralization of Pathogenic JC Polyomaviruses.

Authors:  Eileen M Geoghegan; Diana V Pastrana; Rachel M Schowalter; Upasana Ray; Wei Gao; Mitchell Ho; Gary T Pauly; Dina M Sigano; Campbell Kaynor; Ellen Cahir-McFarland; Benoit Combaluzier; Jan Grimm; Christopher B Buck
Journal:  Cell Rep       Date:  2017-10-31       Impact factor: 9.423

7.  JC Polyomavirus Entry by Clathrin-Mediated Endocytosis Is Driven by β-Arrestin.

Authors:  Colleen L Mayberry; Ashley N Soucy; Conner R Lajoie; Jeanne K DuShane; Melissa S Maginnis
Journal:  J Virol       Date:  2019-04-03       Impact factor: 5.103

8.  JC Polyomavirus Attachment and Entry: Potential Sites for PML Therapeutics.

Authors:  Colleen L Mayberry; Christian D S Nelson; Melissa S Maginnis
Journal:  Curr Clin Microbiol Rep       Date:  2017-08-01

Review 9.  Sending mixed signals: polyomavirus entry and trafficking.

Authors:  Colleen L Mayberry; Avery Cs Bond; Michael P Wilczek; Kashif Mehmood; Melissa S Maginnis
Journal:  Curr Opin Virol       Date:  2021-03-06       Impact factor: 7.090

Review 10.  Understanding polyomavirus CNS disease - a perspective from mouse models.

Authors:  Katelyn N Ayers; Sarah N Carey; Aron E Lukacher
Journal:  FEBS J       Date:  2021-07-02       Impact factor: 5.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.